These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22472177)

  • 1. Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy.
    DeLay M; Jahangiri A; Carbonell WS; Hu YL; Tsao S; Tom MW; Paquette J; Tokuyasu TA; Aghi MK
    Clin Cancer Res; 2012 May; 18(10):2930-42. PubMed ID: 22472177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
    Jahangiri A; De Lay M; Miller LM; Carbonell WS; Hu YL; Lu K; Tom MW; Paquette J; Tokuyasu TA; Tsao S; Marshall R; Perry A; Bjorgan KM; Chaumeil MM; Ronen SM; Bergers G; Aghi MK
    Clin Cancer Res; 2013 Apr; 19(7):1773-83. PubMed ID: 23307858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.
    Carbonell WS; DeLay M; Jahangiri A; Park CC; Aghi MK
    Cancer Res; 2013 May; 73(10):3145-54. PubMed ID: 23644530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
    Chandra A; Jahangiri A; Chen W; Nguyen AT; Yagnik G; Pereira MP; Jain S; Garcia JH; Shah SS; Wadhwa H; Joshi RS; Weiss J; Wolf KJ; Lin JG; Müller S; Rick JW; Diaz AA; Gilbert LA; Kumar S; Aghi MK
    Cancer Res; 2020 Apr; 80(7):1498-1511. PubMed ID: 32041837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.
    Piao Y; Liang J; Holmes L; Henry V; Sulman E; de Groot JF
    Clin Cancer Res; 2013 Aug; 19(16):4392-403. PubMed ID: 23804423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.
    Hu YL; DeLay M; Jahangiri A; Molinaro AM; Rose SD; Carbonell WS; Aghi MK
    Cancer Res; 2012 Apr; 72(7):1773-83. PubMed ID: 22447568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.
    Chinot OL
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1413-27. PubMed ID: 23249106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils promote the malignant glioma phenotype through S100A4.
    Liang J; Piao Y; Holmes L; Fuller GN; Henry V; Tiao N; de Groot JF
    Clin Cancer Res; 2014 Jan; 20(1):187-98. PubMed ID: 24240114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.
    Piao Y; Liang J; Holmes L; Zurita AJ; Henry V; Heymach JV; de Groot JF
    Neuro Oncol; 2012 Nov; 14(11):1379-92. PubMed ID: 22965162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapy of brain tumors: the role of bevacizumab.
    Trevisan E; Bertero L; Bosa C; Magistrello M; Pellerino A; Rudà R; Soffietti R
    Neurol Sci; 2014 Apr; 35(4):507-14. PubMed ID: 24442487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of avastin in the management of recurrent glioblastoma.
    Sweet JA; Feinberg ML; Sherman JH
    Neurosurg Clin N Am; 2012 Apr; 23(2):331-41, x. PubMed ID: 22440876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
    Kickingereder P; Radbruch A; Burth S; Wick A; Heiland S; Schlemmer HP; Wick W; Bendszus M; Bonekamp D
    Radiology; 2016 May; 279(2):542-52. PubMed ID: 26579564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacy.
    de Groot J; Reardon DA; Batchelor TT
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.
    Mahase S; Rattenni RN; Wesseling P; Leenders W; Baldotto C; Jain R; Zagzag D
    Am J Pathol; 2017 May; 187(5):940-953. PubMed ID: 28284719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effect of bevacizumab on glioblastoma cell lines in vitro.
    Simon T; Coquerel B; Petit A; Kassim Y; Demange E; Le Cerf D; Perrot V; Vannier JP
    Neuromolecular Med; 2014 Dec; 16(4):752-71. PubMed ID: 25113866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapies for glioblastoma.
    Arrillaga-Romany I; Norden AD
    CNS Oncol; 2014; 3(5):349-58. PubMed ID: 25363007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab for glioblastoma: current indications, surgical implications, and future directions.
    Castro BA; Aghi MK
    Neurosurg Focus; 2014 Dec; 37(6):E9. PubMed ID: 25581938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma stem cell maintenance: the role of the microenvironment.
    Heddleston JM; Hitomi M; Venere M; Flavahan WA; Yang K; Kim Y; Minhas S; Rich JN; Hjelmeland AB
    Curr Pharm Des; 2011; 17(23):2386-401. PubMed ID: 21827414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.